ES8507612A1 - Un metodo para determinar la presencia de una secuencia natural de restos aminoacidos de un protenoide. - Google Patents
Un metodo para determinar la presencia de una secuencia natural de restos aminoacidos de un protenoide.Info
- Publication number
- ES8507612A1 ES8507612A1 ES534510A ES534510A ES8507612A1 ES 8507612 A1 ES8507612 A1 ES 8507612A1 ES 534510 A ES534510 A ES 534510A ES 534510 A ES534510 A ES 534510A ES 8507612 A1 ES8507612 A1 ES 8507612A1
- Authority
- ES
- Spain
- Prior art keywords
- proteinoids
- diagnostics
- receptors
- translated
- brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 210000004556 brain Anatomy 0.000 title abstract 2
- 108020004999 messenger RNA Proteins 0.000 title abstract 2
- 125000000539 amino acid group Chemical group 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
- G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/686—Anti-idiotype
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
METODO PARA DETERMINAR LA PRESENCIA DE UNA SECUENCIA NATURAL DE RESTOS AMINOACIDOS DE UN PROTEINOIDE.COMPRENDE: A) PROPORCIONAR UN TEJIDO CELULAR QUE PUEDE CONTENER UN PROTEINOIDE O UN DERIVADO PROTEINOIDE; B) MEZCLAR EL TEJIDO DE (A) CON CANTIDADES EFECTIVAS DE UN RECEPTOR BIOLOGICAMENTE ACTIVO O UN CONJUGADO DEL POLIPEPTIDO SINTETICO UNIDO A UN PORTADOR, Y UN GRUPO INDICADOR; C) INCUBAR LA MEZCLA DE (B) DURANTE UN TIEMPO SUFICIENTE PARA QUE SE PRODUZCA UNA REACCION INMUNE; Y D) ENSAYAR LA MEZCLA INCUBADA PARA DETERMINAR LA PRESENCIA DE UNA REACCION INMUNE ENTRE EL PROTEINOIDE O DERIVADO PROTENINOIDE CONTENIDO EN EL TEJIDO CELULAR CEREBRAL Y EL RECEP
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51613683A | 1983-07-21 | 1983-07-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8507612A1 true ES8507612A1 (es) | 1985-09-16 |
ES534510A0 ES534510A0 (es) | 1985-09-16 |
Family
ID=24054282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES534510A Granted ES534510A0 (es) | 1983-07-21 | 1984-07-20 | Un metodo para determinar la presencia de una secuencia natural de restos aminoacidos de un protenoide. |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0135277B1 (es) |
JP (1) | JPS60190796A (es) |
KR (1) | KR850000920A (es) |
AT (1) | ATE23169T1 (es) |
AU (1) | AU576508B2 (es) |
CA (1) | CA1247521A (es) |
DE (1) | DE3461093D1 (es) |
ES (1) | ES534510A0 (es) |
PH (2) | PH21409A (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1987001374A2 (en) * | 1985-08-28 | 1987-03-12 | George Pieczenik | Method and means for sorting and identifying biological information |
US5866363A (en) | 1985-08-28 | 1999-02-02 | Pieczenik; George | Method and means for sorting and identifying biological information |
EP0297585A3 (en) * | 1987-07-01 | 1990-05-23 | Sloan-Kettering Institute For Cancer Research | Neuronal polypeptide and methods of production and use thereof |
FR2660757B1 (fr) * | 1990-04-06 | 1994-05-27 | Immunotech Sa | Procede d'identification ou de dosage de proteines et applications. |
US6743892B1 (en) | 1995-09-11 | 2004-06-01 | La Jolla Cancer Research Foundation | Molecules that home to a selected organ in vivo |
DE69637395T2 (de) * | 1995-09-11 | 2008-12-18 | La Jolla Cancer Research Foundation, La Jolla | Moleküle, die sich in ausgewählten Organen oder Geweben in-vivo einfinden |
US6068829A (en) * | 1995-09-11 | 2000-05-30 | The Burnham Institute | Method of identifying molecules that home to a selected organ in vivo |
US6576239B1 (en) | 1996-09-10 | 2003-06-10 | The Burnham Institute | Angiogenic homing molecules and conjugates derived therefrom |
US6232287B1 (en) | 1998-03-13 | 2001-05-15 | The Burnham Institute | Molecules that home to various selected organs or tissues |
US7544767B2 (en) | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
US8176811B2 (en) * | 2004-07-30 | 2012-05-15 | Dana Heavy Vehicle Systems Group, Llc | Ribbed cover for drive axle housing |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3949064A (en) * | 1973-10-26 | 1976-04-06 | Baxter Laboratories, Inc. | Method of detecting antigens or antibodies |
US4205057A (en) * | 1978-01-17 | 1980-05-27 | Government Of The United States | Cerebrospinal fluid protein fragments |
-
1984
- 1984-07-11 DE DE8484304747T patent/DE3461093D1/de not_active Expired
- 1984-07-11 AT AT84304747T patent/ATE23169T1/de not_active IP Right Cessation
- 1984-07-11 PH PH30967A patent/PH21409A/en unknown
- 1984-07-11 EP EP84304747A patent/EP0135277B1/en not_active Expired
- 1984-07-18 AU AU30813/84A patent/AU576508B2/en not_active Ceased
- 1984-07-20 CA CA000459320A patent/CA1247521A/en not_active Expired
- 1984-07-20 ES ES534510A patent/ES534510A0/es active Granted
- 1984-07-20 JP JP59151146A patent/JPS60190796A/ja active Pending
- 1984-07-20 KR KR1019840004285A patent/KR850000920A/ko not_active Application Discontinuation
-
1987
- 1987-03-04 PH PH34962A patent/PH22909A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPS60190796A (ja) | 1985-09-28 |
AU3081384A (en) | 1985-01-24 |
PH21409A (en) | 1987-10-15 |
DE3461093D1 (en) | 1986-12-04 |
ATE23169T1 (de) | 1986-11-15 |
AU576508B2 (en) | 1988-09-01 |
KR850000920A (ko) | 1985-03-14 |
EP0135277B1 (en) | 1986-10-29 |
CA1247521A (en) | 1988-12-28 |
ES534510A0 (es) | 1985-09-16 |
PH22909A (en) | 1989-01-24 |
EP0135277A1 (en) | 1985-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9303023D0 (en) | Peptide nucleicadis and method for producing them | |
ES8507612A1 (es) | Un metodo para determinar la presencia de una secuencia natural de restos aminoacidos de un protenoide. | |
DE69232585T2 (de) | Oligosidderivat aus einem polyosidantigen von einem pathogenen erreger | |
ATE90690T1 (de) | Menschliche somatomedin-traeger-proteinuntereinheiten und verfahren zu ihrer herstellung. | |
IL126044A0 (en) | Engineering affinity ligands for macromolecules | |
EP0318554A4 (en) | MUTIFUNCTIONAL PROTEINS WITH A PREDETERMINED TARGET. | |
DK1026239T3 (da) | Ny fremgangsmåde til at udnytte det immunologiske repertoire | |
IL136728A0 (en) | Novel g protein-coupled receptor | |
ATE143376T1 (de) | Gegen die beta-kette des leukozyten-adhäsions- rezeptors gerichtete monoklonale antikörper, verfahren zu ihrer herstellung und ihre verwendung | |
IL193886A0 (en) | Antibodies that bind to ldcam sequences | |
DE69000125D1 (de) | Verfahren zum verbinden von elementen zur herstellung von teilen aus mehrstrukturellem verbundmaterial. | |
DE69734096D1 (de) | Rezeptor des ob-proteins und verwandte zusammensetzungen und verfahren | |
DE69327059D1 (de) | Verfahren zur herstellung von testelementen | |
DE3581288D1 (de) | Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen. | |
EP0257778A3 (en) | Apolipoprotein b-specific monoclonal antibodies produced by two novel hybridomas | |
DE3482021D1 (de) | Verfahren zur erhoehung der milchleistung von milchliefernden kuehen mittels futter, verfahren zur herstellung dieses futters und apparat zur durchfuehrung dieses verfahrens. | |
EP0861838A3 (en) | Process and intermediates for preparing cryptophycin compounds | |
ATE216778T1 (de) | Verfahren zur herstellung von konjugaten aus einem spezifischen bindungspartner und einem kohlenhydrathaltigen protein | |
DE69810959D1 (de) | Verfahren zur herstellung von pyrrolamiden | |
EP1584925A4 (en) | NEW SCREENING PROCEDURE | |
DE69000705D1 (de) | Kupferderivat oder kupfer- und borderivat enthaltendes schmieroeladditiv, verfahren zu seiner herstellung und dieses additiv enthaltende zusammensetzungen. | |
NZ237533A (en) | Monoclonal antibodies which bind to oncostatin m, cell lines producing them | |
DE58900392D1 (de) | Verfahren zum chargieren von roheisen, sowie vorrichtung zur durchfuehrung dieses verfahrens. | |
BG101927A (en) | Peprides having growth acceleration properties | |
MY115259A (en) | Process for the preparation of nmda antagonists |